000110766 001__ 110766
000110766 005__ 20230830110641.0
000110766 0247_ $$2doi$$a10.1007/s12144-021-01392-5
000110766 0248_ $$2sideral$$a123392
000110766 037__ $$aART-2023-123392
000110766 041__ $$aeng
000110766 100__ $$aAbasi, I.
000110766 245__ $$aPositive emotion regulation strategies as mediators in depression and generalized anxiety disorder symptoms: A Transdiagnostic framework investigation
000110766 260__ $$c2023
000110766 5060_ $$aAccess copy available to the general public$$fUnrestricted
000110766 5203_ $$aPositive emotion regulation (ER) strategies may contribute to the development and maintenance of generalized anxiety disorder (GAD) and depression; nonetheless, the underlying and transdiagnostic mechanisms are still unknown. To examine: 1) the mediating role of positive ER strategies in the relationship between ER deficits and experiential avoidance in GAD and depression symptoms; 2) differences in positive ER strategies among participants with elevated symptoms of GAD, depression, depression comorbid with GAD, and a nonclinical sample. 532 Tehran University students completed questionnaires assessing experiential avoidance, deficits in ER, positive ER strategies (dampening, positive rumination), and GAD and depression symptoms. Differences were assessed in four groups: GAD, depression, depression comorbid with GAD, and nonclinical. Data were analysed with path analysis and MANCOVA. Dampening and positive rumination mediated the relationship between deficits in ER and experiential avoidance in participants with depression and GAD symptoms. As for the between groups comparisons, the comorbid group obtained the highest scores on dampening and the nonclinical group the lowest. By contrast, nonclinical participants had the highest scores on positive rumination, whereas the comorbid group had the lowest. Positive ER strategies might be transdiagnostic variables. Dampening was more associated with psychopathology than positive rumination, suggesting that this strategy could be more clearly considered a transdiagnostic factor. Future studies with clinical samples must support this suggestion.
000110766 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000110766 590__ $$a2.387$$b2021
000110766 592__ $$a0.513$$b2021
000110766 594__ $$a3.4$$b2021
000110766 591__ $$aPSYCHOLOGY, MULTIDISCIPLINARY$$b73 / 146 = 0.5$$c2021$$dQ2$$eT2
000110766 593__ $$aPsychology (miscellaneous)$$c2021$$dQ2
000110766 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000110766 700__ $$aShams, G.
000110766 700__ $$0(orcid)0000-0003-3075-7912$$aPascual-Vera, B.
000110766 700__ $$aMilosevic, I.
000110766 700__ $$aBitarafan, M.
000110766 700__ $$aGhanadanzadeh, S.
000110766 700__ $$aTalebi Moghaddam, M.
000110766 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac
000110766 773__ $$g42, 1 (2023), 800–807$$pCurr. psychol.$$tCurrent Psychology$$x1046-1310
000110766 8564_ $$s207188$$uhttps://zaguan.unizar.es/record/110766/files/texto_completo.pdf$$yPostprint
000110766 8564_ $$s2405813$$uhttps://zaguan.unizar.es/record/110766/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000110766 909CO $$ooai:zaguan.unizar.es:110766$$particulos$$pdriver
000110766 951__ $$a2023-08-30-10:58:32
000110766 980__ $$aARTICLE